BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2871053)

  • 21. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological salvage of myocardium.
    Lange LG; Sobel BE
    Annu Rev Pharmacol Toxicol; 1982; 22():115-43. PubMed ID: 6123293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute coronary artery obstruction in myocardial infarction: overview of thrombolytic therapy.
    Hugenholtz PG
    J Am Coll Cardiol; 1987 Jun; 9(6):1375-84. PubMed ID: 3108346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reperfusion in acute myocardial infarction.
    Lavie CJ; Gersh BJ; Chesebro JH
    Mayo Clin Proc; 1990 Apr; 65(4):549-64. PubMed ID: 2332994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapies to limit infarct size. Timing, dosage, and effectiveness.
    Peterson JE; Emmot WW
    Postgrad Med; 1989 Sep; 86(3):54-9, 63. PubMed ID: 2505243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [PTCA in acute myocardial infarct: primary, immediate, delayed or elective?].
    Rutsch W
    Herz; 1992 Feb; 17(1):50-63. PubMed ID: 1541450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of beta-adrenergic blocking agents in acute myocardial infarction (author's transl)].
    Wirtzfeld A; Klein G; Himmler FC; Schmidt G
    Herz; 1981 Apr; 6(2):73-83. PubMed ID: 6112196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation between flow grade after thrombolytic therapy and the effect of angioplasty on left ventricular function: a prospective randomized trial.
    Belenkie I; Knudtson ML; Roth DL; Hansen JL; Traboulsi M; Hall CA; Manyari D; Filipchuck NG; Schnurr LP; Rosenal TW
    Am Heart J; 1991 Feb; 121(2 Pt 1):407-16. PubMed ID: 1990744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early intervention in acute myocardial infarction: one center's perspective.
    Sobel BE
    Am J Cardiol; 1984 Dec; 54(11):2E-7E. PubMed ID: 6150633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The possible limits of thrombolysis: reocclusion and reperfusion damage].
    Ambrosio G; Golino P; Chiariello M
    Cardiologia; 1991 Dec; 36(12 Suppl 1):421-33. PubMed ID: 1841798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Advances in intracoronary thrombolysis treatment].
    Kawai C
    J Cardiol; 1988 Dec; 18(4):1149-53. PubMed ID: 3267723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic management of ischemic heart disease with beta-blockers and calcium channel blockers.
    Pearle DL
    Am Heart J; 1990 Sep; 120(3):739-42; discussion 743-5. PubMed ID: 1975155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An overview of therapeutic interventions in myocardial infarction. Emphasis on secondary prevention.
    Hinstridge V; Speight TM
    Drugs; 1991; 42 Suppl 2():8-20. PubMed ID: 1718703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment of myocardial infarction. Treatment of Post-Thrombolytic Stenoses (TOPS) Study Group.
    Ellis SG; Mooney MR; George BS; da Silva EE; Talley JD; Flanagan WH; Topol EJ
    Circulation; 1992 Nov; 86(5):1400-6. PubMed ID: 1423952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of the long term effects of thrombolytic agents.
    van Domburg RT; Boersma E; Simoons ML
    Drugs; 2000 Aug; 60(2):293-305. PubMed ID: 10983734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombolytic therapy in acute myocardial infarction: Part I.
    Mueller HS; Roberts R; Teichman SL; Sobel BE
    Med Clin North Am; 1988 Jan; 72(1):197-226. PubMed ID: 3276985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; SchirĂ² M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombolysis in postinfarction angina.
    Ouyang P; Shapiro EP; Gottlieb SO
    Am J Cardiol; 1991 Sep; 68(7):119B-124B. PubMed ID: 1892059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.